This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stocks Close Higher on U.S. Home Sales, Prospects for Central Bank Easing

Stocks in this article: ^DJI ^GSPC ^IXIC THC MCO MS MHP

NEW YORK ( TheStreet) -- U.S. stock markets gained Monday led by health care stocks after a report showed an improvement in home contract signings, a positive sign on national housing demand and economic momentum.

The S&P 500 added 0.7% to close at 1,593.60 while the S&P Healthcare Facilities Index was surging 6.8%.

The National Association of Realtors reported Monday that home contract signings rose to a five-year high in March excluding a surge related to the home-buyer tax credit. The index gained 1.5% last month after falling by a downwardly-revised decline of 1% in February. Economists, on average, were expecting a gain of 1%, according to a Thomson Reuters survey.

"The March pending sales reading likely points to a pick-up in existing home sales in April following a somewhat softer pace of home-buying activity at the start of the year," Yelena Shulyatyeva, an economist at BNP Paribas in New York, said in a client note.

Tenet Healthcare Corp. (THC) jumped 6.5% to $43.84 after Robert Bairdand UBS raised their ratings to buy or an equivalent. Robert Baird analysts gave the health care company a 12-month price target of $51 on grounds that its Medicare reimbursement rates should rise. UBS noted that the Centers for Medicare and Medicaid Services-proposed Medicare net IPPS was better than expected.

Moody's (MCO) surged 8.3% to $59.69 after the Associated Press reported over the weekend that it had settled a lawsuit with McGraw-Hill Companies' (MHP) Standard & Poor's unit and Morgan Stanley (MS) dating back to the financial crisis. McGraw-Hill was advancing 2.8% to $53.45 and Morgan Stanley was up 3.8% to $22.21.

Markets also appeared buoyed by indications central banks around the world will continue implementing measures to stimulate their respective economies as the Bureau of Economic Analysis reported that the core PCE price index dropped to 1.1% year-over-year in March after being unchanged on a monthly basis as personal spending ticked up 0.2% in March and personal income rose 0.2%.

"The overall picture is the same--inflation has been steadily decelerating over the past year. This will be noticed and discussed at length at this week's FOMC meeting and will keep the Fed committed to expansionary policy," noted Julia Coronado, chief economist for North America at BNP Paribas in New York.

The U.S. Federal Reserve is scheduled to make an announcement following its two-day policy meeting that ends on Wednesday while the European Central Bank is expected to do the same on Thursday. UBS Economics estimates that the ECB's Governing Council will likely to cut its benchmark refinance rate by 25 basis points to 0.5%.

--Written by Andrea Tse in New York

>To contact the writer of this article, click here: Andrea Tse.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,652.44 +295.57 1.70%
S&P 500 2,048.04 +35.15 1.75%
NASDAQ 4,730.8750 +86.5630 1.86%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs